Literature DB >> 12698257

A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma.

Hiroshi Kobayashi1, Kaori Kobayashi, Satoshi Okinami.   

Abstract

PURPOSE: To compare the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C.
METHODS: Twenty-five patients with bilateral primary open-angle glaucoma were enrolled in a prospective clinical study. The eyes of each patient were randomly assigned to receive viscocanalostomy in one eye and trabeculectomy with mitomycin C in the other eye. The patients were followed up for 12 months. At each visit, best-corrected visual acuity, intraocular pressure, and the appearance of the surgical wound, anterior chamber, and indirect ophthalmoscopy were recorded.
RESULTS: The mean baseline intraocular pressure was 25.0+/-2.2 mmHg in viscocanalostomy-treated eyes and 24.8+/-2.6 mmHg in trabeculectomy-treated eyes. The mean postoperative intraocular pressure was 15.3+/-1.7 mmHg, 17.1+/-1.5 mmHg, and 17.1+/-1.5 mmHg in viscocanalostomy-treated eyes and 11.7+/-4.4 mmHg, 11.8+/-4.6 mmHg, and 12.6+/-4.3 mmHg in trabeculectomy-treated eyes at 3-, 6- and 12-month intervals, respectively. The mean intraocular pressure in viscocanalostomy-treated eyes was significantly higher than that in trabeculectomy-treated eyes at every visit (P<0.0001). At 12 months, 16 viscocanalostomy-treated eyes (64%) and 22 trabeculectomy-treated eyes (88%) achieved an intraocular pressure of less than or equal to 20 mmHg without medication; there was a significant difference between the two groups (P=0.0240). There were fewer complications in viscocanalostomy-treated eyes. Complications included four cases of shallow anterior chamber (16%) and five of hypotony (20%) in trabeculectomy-treated eyes, against intraoperative microperforation of Descemet's membrane in one of viscocanalostomy-treated eye (4%).
CONCLUSION: Trabeculectomy with mitomycin C may be more effective than viscocanalostomy in lowering intraocular pressure in patients with primary open-angle glaucoma, while eyes undergoing viscocanalostomy experience a lower incidence of complications. Further investigation of more cases is needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12698257     DOI: 10.1007/s00417-003-0652-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  22 in total

1.  Viscocanalostomy for open-angle glaucoma in black African patients.

Authors:  R Stegmann; A Pienaar; D Miller
Journal:  J Cataract Refract Surg       Date:  1999-03       Impact factor: 3.351

2.  Dilation of Schlemm's canal in viscocanalostomy: comparison of 2 viscoelastic substances.

Authors:  G J Wild; A R Kent; Q Peng
Journal:  J Cataract Refract Surg       Date:  2001-08       Impact factor: 3.351

3.  Results of viscocanalostomy for primary open-angle glaucoma.

Authors:  G Sunaric-Mégevand; P M Leuenberger
Journal:  Am J Ophthalmol       Date:  2001-08       Impact factor: 5.258

4.  Trabeculectomy. Preliminary report of a new method.

Authors:  J E Cairns
Journal:  Am J Ophthalmol       Date:  1968-10       Impact factor: 5.258

5.  Trabeculectomy vs. nonpenetrating trabeculectomy: a retrospective study of two procedures in phakic patients with glaucoma.

Authors:  T J Zimmerman; K S Kooner; V J Ford; K W Olander; R M Mandlekorn; E F Rawlings; B J Leader; A J Koskan
Journal:  Ophthalmic Surg       Date:  1984-09

6.  Characteristics and risk factors of infections after glaucoma filtering surgery.

Authors:  E J Poulsen; R R Allingham
Journal:  J Glaucoma       Date:  2000-12       Impact factor: 2.503

7.  The influence of high molecular weight sodium hyaluronate (Healon) on the production of migration inhibitory factor.

Authors:  R van der Gaag; L Broersma; L Koornneef
Journal:  Curr Eye Res       Date:  1987-12       Impact factor: 2.424

8.  Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma.

Authors:  F El Sayyad; M Helal; H El-Kholify; M Khalil; A El-Maghraby
Journal:  Ophthalmology       Date:  2000-09       Impact factor: 12.079

9.  Inhibition of phagocytosis by high molecular weight hyaluronate.

Authors:  J V Forrester; E A Balazs
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

10.  Inhibition of leukocyte locomotion by hyaluronic acid.

Authors:  J V Forrester; P C Wilkinson
Journal:  J Cell Sci       Date:  1981-04       Impact factor: 5.285

View more
  6 in total

1.  Viscocanalostomy versus trabeculectomy in patients with bilateral high-tension glaucoma.

Authors:  Alper Yarangümeli; Serkan Güreser; Ozlem Gürbüz Köz; Atilla Halil Elhan; Gülcan Kural
Journal:  Int Ophthalmol       Date:  2005-09-29       Impact factor: 2.031

2.  Nd:YAG laser goniopuncture in viscocanalostomy: penetration in non-penetrating glaucoma surgery.

Authors:  Mehmet Numan Alp; Alper Yarangumeli; Ozlem Gurbuz Koz; Gulcan Kural
Journal:  Int Ophthalmol       Date:  2009-05-29       Impact factor: 2.031

3.  A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy.

Authors:  D P S O'Brart; M Shiew; B Edmunds
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

Review 4.  Systematic overview of the efficacy of nonpenetrating glaucoma surgery in the treatment of open angle glaucoma.

Authors:  Jin-Wei Cheng; Shi-Wei Cheng; Ji-Ping Cai; You Li; Rui-Li Wei
Journal:  Med Sci Monit       Date:  2011-07

5.  Deep Sclerectomy with Goniosynechiolysis Ab Interno for Chronic Glaucoma Associated with Peripheral Anterior Synechiae.

Authors:  Alireza Mirshahi; Peter Raak; Katharina Ponto; Bernhard Stoffelns; Katrin Lorenz; Gábor B Scharioth
Journal:  J Ophthalmol       Date:  2015-06-23       Impact factor: 1.909

6.  The efficacy of Viscocanalostomies and combined phacoemulsification with Viscocanalostomies in the treatment of patients with glaucoma: a non-randomised observational study.

Authors:  Andrew Want; Derek K-H Ho; Bhavani Karri; Divya Mathews
Journal:  BMC Ophthalmol       Date:  2018-05-02       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.